1. Home
  2. NVCT vs IDE Comparison

NVCT vs IDE Comparison

Compare NVCT & IDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • IDE
  • Stock Information
  • Founded
  • NVCT 2020
  • IDE 2010
  • Country
  • NVCT United States
  • IDE United States
  • Employees
  • NVCT N/A
  • IDE N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • IDE Finance/Investors Services
  • Sector
  • NVCT Health Care
  • IDE Finance
  • Exchange
  • NVCT Nasdaq
  • IDE Nasdaq
  • Market Cap
  • NVCT 184.9M
  • IDE 177.2M
  • IPO Year
  • NVCT 2022
  • IDE N/A
  • Fundamental
  • Price
  • NVCT $7.78
  • IDE $11.88
  • Analyst Decision
  • NVCT Strong Buy
  • IDE
  • Analyst Count
  • NVCT 3
  • IDE 0
  • Target Price
  • NVCT $17.00
  • IDE N/A
  • AVG Volume (30 Days)
  • NVCT 265.7K
  • IDE 33.5K
  • Earning Date
  • NVCT 08-05-2025
  • IDE 01-01-0001
  • Dividend Yield
  • NVCT N/A
  • IDE 8.83%
  • EPS Growth
  • NVCT N/A
  • IDE N/A
  • EPS
  • NVCT N/A
  • IDE N/A
  • Revenue
  • NVCT N/A
  • IDE N/A
  • Revenue This Year
  • NVCT N/A
  • IDE N/A
  • Revenue Next Year
  • NVCT N/A
  • IDE N/A
  • P/E Ratio
  • NVCT N/A
  • IDE N/A
  • Revenue Growth
  • NVCT N/A
  • IDE N/A
  • 52 Week Low
  • NVCT $4.44
  • IDE $8.61
  • 52 Week High
  • NVCT $11.80
  • IDE $10.46
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 44.12
  • IDE 69.67
  • Support Level
  • NVCT $7.70
  • IDE $11.69
  • Resistance Level
  • NVCT $8.24
  • IDE $11.78
  • Average True Range (ATR)
  • NVCT 0.44
  • IDE 0.08
  • MACD
  • NVCT 0.03
  • IDE 0.00
  • Stochastic Oscillator
  • NVCT 27.52
  • IDE 93.94

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

Share on Social Networks: